v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenues $ 4,740 $ 18,393 $ 15,965 $ 24,272
Cost of goods sold 4,167 16,756 11,021 21,399
Gross profit 573 1,637 4,944 2,873
Operating expenses        
General and administrative 5,817 5,906 11,882 13,802
Research and development 1,899 2,087 3,929 4,017
Sales and marketing 804 707 1,720 1,361
Total operating expenses 8,520 8,700 17,531 19,180
Loss from operations (7,947) (7,063) (12,587) (16,307)
Other income (expense), net 1,096 (405) 816 (1,256)
Change in fair value of derivative instruments (15) (6) (6) (60)
Loss before provision for income taxes (6,866) (7,474) (11,777) (17,623)
Provision for income taxes 27 13 32 25
Net loss $ (6,893) $ (7,487) $ (11,809) $ (17,648)
Net loss per share        
Basic $ (0.55) $ (0.9) $ (0.98) $ (2.16)
Diluted $ (0.55) $ (0.9) $ (0.98) $ (2.16)
Weighted average shares outstanding        
Basic 12,591 8,287 12,084 8,182
Diluted [1] 12,591 8,287 12,084 8,182
[1] Net loss attributable to common stockholders, diluted during both the three and six months ended June 30, 2026 and 2025, excludes adjustments related to the change in fair value of derivative liabilities, interest expense and amortization of discounts and issuance costs related to Convertible Note. These adjustments were excluded from the calculation of diluted net loss per share as they would have an antidilutive effect (see Note 8 — Convertible Notes).